SCHEMBL574173

SCHEMBL574173

CCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
BLM P54132 1/20 0.47
SLC12A2 P55011 1/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CISD1 Q9NZ45 10/20 0.47
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
HTT P42858 1/20 0.46
GFER P55789 1/20 0.46
PLEC Q15149 1/20 0.46
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL573193 0.87 CA2 (0.64) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL573694 0.84 PKM (0.44) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL15367494 0.78 CISD1 (0.42) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL9042101 0.78 CA1 (0.56) CA2ALDH1A1LMNATSHRCISD1
SCHEMBL16645764 0.76 CA1 (0.53) CA2ALDH1A1HPGDLMNAHIF1A
SCHEMBL7824144 0.76 KDM4E (0.48) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL16581064 0.76 CISD1 (0.56) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL10224099 0.76 KDM4E (0.80) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL574542 0.75 KMT2A (0.46) CA2KDM4EALDH1A1HPGDUSP2
SCHEMBL7824071 0.74 SMN1; SMN2 (0.52) CA2KDM4EALDH1A1HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed